Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Recombinant Human Clara Cell Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome

NCT01941745 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT01941745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01941745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Recombinant Human Clara Cell Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Lead sponsor
Tufts Medical Center
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
August 25, 2017
Enrollment
88 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, respiratory distress syndrome in premature infant